Literature DB >> 12060668

Purification and characterization of a cyclooxygenase-2 and angiogenesis suppressing factor produced by human fibroblasts.

Wu-Guo Deng1, Michael A Saunders, Derek W Gilroy, Xue-Zhong He, Howard Yeh, Ying Zhu, Mikhail I Shtivelband, Ke-He Ruan, Kenneth K Wu.   

Abstract

Cyclooxygenase-2 (COX-2) is an inducible enzyme that plays an important role in several pathophysiological processes, including inflammation, angiogenesis, and tumorigenesis. We have recently observed that COX-2 induction is restrained in proliferating fibroblasts. The mechanism by which this occurs is unclear. Here, we report the detection and isolation from the conditioned medium of proliferating fibroblasts a factor that suppressed COX-2 expression. This factor, which was named cytoguardin, suppressed COX-2 protein levels induced by phorbol 12-myristate 13-acetate, interleukin-1beta, tumor necrosis factor alpha, and lipopolysaccharide (LPS) in fibroblasts and LPS-induced COX-2 protein levels and promoter activities in human endothelial cells and murine RAW 264.7 cells in a comparable concentration-dependent manner. It inhibited COX-2 expression induced by angiogenic factors and endothelial tube formation induced by angiogenic factors and colon cancer cell medium. These findings provide evidence for the control of COX-2 transcription by an endogenous cellular factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060668     DOI: 10.1096/fj.01-0844fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.

Authors:  Yeon-Joo Kang; Uri R Mbonye; Cynthia J DeLong; Masayuki Wada; William L Smith
Journal:  Prog Lipid Res       Date:  2007-01-18       Impact factor: 16.195

2.  Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.

Authors:  Zhi-Hong Zhang; Qin Ouyang; Hua-Tian Gan
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

3.  Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan.

Authors:  Huei-Hsuan Cheng; Cheng-Chin Kuo; Jiann-Long Yan; Hua-Ling Chen; Wei-Chung Lin; Kai-Hsuan Wang; Kelvin K-C Tsai; Hayrettin Guvén; Emilie Flaberg; Laszlo Szekely; George Klein; Kenneth K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-31       Impact factor: 11.205

4.  Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.

Authors:  Xiangsheng Xiao; Dingbo Shi; Liqun Liu; Jingshu Wang; Xiaoming Xie; Tiebang Kang; Wuguo Deng
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

Review 5.  Control of Mesenchymal Stromal Cell Senescence by Tryptophan Metabolites.

Authors:  Kenneth K Wu
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 6.  Cytoguardin: A Tryptophan Metabolite against Cancer Growth and Metastasis.

Authors:  Kenneth K Wu
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Quiescent fibroblasts are more active in mounting robust inflammatory responses than proliferative fibroblasts.

Authors:  Bo-Rui Chen; Huei-Hsuan Cheng; Wei-Chung Lin; Kai-Hsuan Wang; Jun-Yang Liou; Pei-Feng Chen; Kenneth K Wu
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Quiescent and proliferative fibroblasts exhibit differential p300 HAT activation through control of 5-methoxytryptophan production.

Authors:  Huei-Hsuan Cheng; Kai-Hsuan Wang; Ling-yun Chu; Tzu-Ching Chang; Cheng-Chin Kuo; Kenneth K Wu
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

Review 9.  5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis.

Authors:  Kenneth K Wu; Huei-Hsuan Cheng; Tzu-Ching Chang
Journal:  J Biomed Sci       Date:  2014-03-03       Impact factor: 8.410

10.  Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation.

Authors:  Ling-Yun Chu; Yi-Fu Wang; Huei-Hsuan Cheng; Cheng-Chin Kuo; Kenneth K Wu
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.